Coronaviruses with Special Emphasis on First Insights Concerning SARS

It is with great pleasure that we introduce the first volume of Birkhäuser Advances in Infectious Diseases.This book series will focus on relevant t- ics of microbiology and infectious diseases with emphasis (as much as p- sible) on emerging pathogens and related diseases.The series will also stress...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Schmidt, Axel (Επιμελητής έκδοσης), Weber, Olaf (Επιμελητής έκδοσης), Wolff, Manfred H. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Basel : Birkhäuser Basel, 2005.
Σειρά:Birkhäuser Advances in Infectious Diseases BAID
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03476nam a22004815i 4500
001 978-3-7643-7339-9
003 DE-He213
005 20151031141026.0
007 cr nn 008mamaa
008 100301s2005 sz | s |||| 0|eng d
020 |a 9783764373399  |9 978-3-7643-7339-9 
024 7 |a 10.1007/b137625  |2 doi 
040 |d GrThAP 
050 4 |a RC109-216 
072 7 |a MJCJ  |2 bicssc 
072 7 |a MED022090  |2 bisacsh 
082 0 4 |a 616.9  |2 23 
245 1 0 |a Coronaviruses with Special Emphasis on First Insights Concerning SARS  |h [electronic resource] /  |c edited by Axel Schmidt, Olaf Weber, Manfred H. Wolff. 
264 1 |a Basel :  |b Birkhäuser Basel,  |c 2005. 
300 |a XIV, 232 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Birkhäuser Advances in Infectious Diseases BAID 
505 0 |a Coronaviridae: a review of coronaviruses and toroviruses -- Coronavirus infections in veterinary medicine -- Severe acute respiratory syndrome: clinical features -- SARS coronavirus infection: pathology and pathogenesis of an emerging virus disease -- Genome organization and structural aspects of the SARS-related virus -- Virological laboratory diagnosis of SARS -- Performance evaluation of a Bayer Healthcare Diagnostics research-based SARS coronavirus assay -- Current status of therapy of SARS -- Coronavirus main proteinase: target for antiviral drug therapy -- Environmental survival and microbicide inactivation of coronaviruses -- Disease management strategies in SARS. 
520 |a It is with great pleasure that we introduce the first volume of Birkhäuser Advances in Infectious Diseases.This book series will focus on relevant t- ics of microbiology and infectious diseases with emphasis (as much as p- sible) on emerging pathogens and related diseases.The series will also stress the inter-disciplinarity of the field and include “modern“ aspects such as progress and new approaches in molecular biology, clinical aspects and modern insights relevant to human and veterinary medicine. In addition, questions of epidemiology,disease management,hygiene and prevention of infectious diseases will be discussed. Emerging or recently classified pathogens are a great challenge in m- icine.Therefore we focused the first volume of this series on the outbreak of SARS.The advent of SARS is a threat for people around the globe.Our modern technologies have figuratively transformed the world into a village. It is not a problem anymore for someone or something to travel to or trade with remote parts of the world.This traffic, however, reprensents a new opportunity to spread diseases, particularly such of infectious nature from tiny villages throughout the entire world. 
650 0 |a Medicine. 
650 0 |a Medical microbiology. 
650 0 |a Infectious diseases. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Infectious Diseases. 
650 2 4 |a Medical Microbiology. 
700 1 |a Schmidt, Axel.  |e editor. 
700 1 |a Weber, Olaf.  |e editor. 
700 1 |a Wolff, Manfred H.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783764364625 
830 0 |a Birkhäuser Advances in Infectious Diseases BAID 
856 4 0 |u http://dx.doi.org/10.1007/b137625  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)